Glaucoma Related Quality of Life

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Marc Toeteberg-Harms
Study ID
NCT07510087
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • GQL-15 — OTHER
    GQL-15 questionnaire
  • Glaucoma Symptom Scale — OTHER
    GSS questionnaire
  • NEI Vision Function Questionnaire — OTHER
    Vision function questionnaire
  • Ocular Surface Disease Index — OTHER
    OSDI questionnaire

Study Details

Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.

Key Dates

Start date
Dec 30, 2024
Status verified
Apr 2026
Primary completion
Nov 30, 2026
Completion
May 30, 2027

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Study Arm (glaucoma)
    subjects with a diagnosis of glaucoma

Primary Outcome Measure

Ocular Surface Disease Index (OSDI) [ Time Frame: At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Iowa, Dept. of Ophthalmology & Visual SciencesIowa CityIowa52242
Marc Toeteberg-Harms, MD
[email protected]
+1 319 356 3938
Helen Gomez
[email protected]
+1 319 356 3938
Marc Toeteberg-Harms, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Iowa City, IA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
University of Iowa, Dept. of Ophthalmology & Visual Sciences· Iowa City, IA

Related Studies